SLC25A43 and breast carcinoma: SLC25A43 KO in HER2-positive breast cancer cells (BT-474) increases proliferation and cell cycle progression via enhanced G1-to-S transition, suggesting a role for SLC25A43 as a regulator of the cell cycle through a putative mitochondrial checkpoint [232].